Clinical Trials · NCT06060587
Randomized Phase II Study of ADT + Abiraterone vs ADT + Docetaxel + Abiraterone
- Phase
- Phase 2
- Recruitment status
- Withdrawn
- Sponsor
- Northwestern University
- Enrollment
- 0
- Start date
- Oct 2023
- Locations
- 1 site, United States
- Primary endpoint
- Assess Progression Free Survival (PFS)